人工智能放疗平台结合5G技术实现远程放疗

Artificial intelligence radiotherapy platform combined with 5G technology to realize remote radiotherapy

目的:评估人工智能放疗平台(AiContour)与5G技术结合的可行性,以及通过该结合实现跨区域远程放疗的可行性。方法:选取中国移动作为5G技术服务商,北京连心医疗作为人工智能放疗平台服务商,内江肿瘤医院作为远程放疗服务接收方,构建基于5G技术的人工智能放疗平台远程放疗架构。结果:人工智能放疗平台能够与5G技术结合,放疗医师能通过5G终端随时随地进行肿瘤患者靶区勾画,提升工作效率。同时,跨区域远程放疗模式能够降低市县级肿瘤患者放疗成本,提升肿瘤放疗应用范围。结论:通过5G终端实现肿瘤患者靶区自动勾画可节省放疗医师大量的时间;通过人工智能放疗平台可实现省级优势放疗技术向市县级的扩展,符合国家分级诊疗的要求。

Objective To evaluate the feasibility of combining artificial intelligence radiotherapy platform(AiContour) with5G technology, and to assess the feasibility of realizing cross-regional remote radiotherapy through this combination.Methods By taking China Mobile as the 5G technology service provider, Beijing Liningmed as the artificial intelligence radiotherapy platform service provider, and Neijiang Cancer Hospital as the remote radiotherapy service receiver, the remote radiotherapy architecture on artificial intelligence radiotherapy platform was constructed based on 5G technology. Results Artificial intelligence radiotherapy platform could be combined with 5G technology, and radiotherapy physicians could realize the target area segmentation anytime and anywhere through 5G terminals, which improved work efficiency.Meanwhile, the cross-regional remote radiotherapy model reduced the cost of radiotherapy for tumor patients at municipal and county-level hospitals, and improved the application range of tumor radiotherapy. Conclusion The automatic segmentation of target areas through 5G terminal saves a lot of time for radiotherapy physicians. The extension of provincial superior radiotherapy technology to municipal and county-level hospitals through artificial intelligence radiotherapy platform is in line with the requirements of national hierarchical diagnosis and treatment.